Quidel Ortho Reagents, Consumables and Maintenance

This is a firm-fixed-price contract awarded non-competitively to Quidel Ortho Sales Company, LLC for the supply of FDA-approved reagents, consumables, and maintenance services to support two Government-owned Quidel Ortho Vision Swift Analyzers located at the 96th Medical Group laboratory in Goulds, Florida. The contract, issued by the Defense Health Agency under solicitation number HT940826FE032, has a base period from June 1, 2026, through September 30, 2026, with four consecutive one-year option periods extending through September 30, 2030, all funded under Operations and Maintenance appropriations. The sole-source award was justified under FAR 8.401 due to the exclusive regulatory and technical requirements that limit availability to the original equipment manufacturer only. The reagents must comply with FDA regulations including 21 CFR Part 606 and 660, be properly labeled, and fully compatible with the designated analyzers; maintenance services include software updates, technical support, and access to field service engineers. No competitive evaluation process was conducted; award was based on a best value determination resulting from market research that confirmed Quidel Ortho as the sole provider capable of meeting all mandatory technical, regulatory, and operational criteria. The contract is administered from San Antonio, Texas, with Marcus Mattingly serving as the primary point of contact, and performance is required at the specified location in Florida. The delivery schedule is fixed and recurring, with no bar-coding or military packaging standards mandated, and acceptance is tied to strict FDA compliance and system compatibility. All contractual obligations are firm-fixed-price, with no pricing details publicly disclosed, and no alternate contractors or subcontracting mechanisms were considered or required.